FR2099730A5 - - Google Patents

Info

Publication number
FR2099730A5
FR2099730A5 FR7028410A FR7028410A FR2099730A5 FR 2099730 A5 FR2099730 A5 FR 2099730A5 FR 7028410 A FR7028410 A FR 7028410A FR 7028410 A FR7028410 A FR 7028410A FR 2099730 A5 FR2099730 A5 FR 2099730A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7028410A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Application granted granted Critical
Publication of FR2099730A5 publication Critical patent/FR2099730A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7028410A 1970-07-15 1970-07-31 Expired FR2099730A5 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5524070A 1970-07-15 1970-07-15

Publications (1)

Publication Number Publication Date
FR2099730A5 true FR2099730A5 (OSRAM) 1972-03-17

Family

ID=21996600

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7028410A Expired FR2099730A5 (OSRAM) 1970-07-15 1970-07-31

Country Status (8)

Country Link
US (1) US3755322A (OSRAM)
AT (2) AT299216B (OSRAM)
AU (1) AU1826570A (OSRAM)
BE (1) BE754242A (OSRAM)
CA (1) CA982577A (OSRAM)
FR (1) FR2099730A5 (OSRAM)
GB (1) GB1339749A (OSRAM)
NL (1) NL7011392A (OSRAM)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0945447A1 (en) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
WO2000027828A3 (en) * 1998-11-10 2000-09-21 Janssen Pharmaceutica Nv 2,4-disubstituted triazine derivatives with anti hiv activity
WO2006024175A1 (en) * 2004-09-03 2006-03-09 Prometic Biosciences Inc. 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
US7241458B1 (en) 1999-09-24 2007-07-10 Janssen Pharmaceutica N.V. Antiviral compositions

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928344A (en) * 1971-12-27 1975-12-23 Degussa Phenylenediamine-s-triazines
IT1060458B (it) * 1975-12-18 1982-08-20 Chimosa Chimica Organica Spa Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
DE3006803A1 (de) * 1980-02-23 1981-09-03 Bayer Ag, 5090 Leverkusen Vulkanisationsbeschleuniger auf basis von melaminderivaten, melaminderivate enthaltende kautschukmassen sowie ein verfahren zur vulkanisation von kautschuken
DE3401675A1 (de) * 1984-01-19 1985-07-25 Bayer Ag, 5090 Leverkusen Neue polyamine und ein verfahren zu ihrer herstellung
DE3438694A1 (de) * 1984-10-23 1986-04-24 Basf Ag, 6700 Ludwigshafen Neue amidoalkylmelamine und aminoalkylmelamine und verfahren zu ihrer herstellung
US6225378B1 (en) * 1999-07-01 2001-05-01 Industrial Technology Research Institute Triazine hardener and epoxy composition containing the same
US6660731B2 (en) * 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
ES2266258T3 (es) * 2000-09-15 2007-03-01 Vertex Pharmaceuticals Incorporated Compuestos de pirazol utiles como inhibidores de proteina cinasas.
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
EP1345925B1 (en) * 2000-12-21 2006-05-17 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
RU2004126671A (ru) * 2002-02-06 2005-04-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
EP1485380B1 (en) * 2002-03-15 2010-05-19 Vertex Pharmaceuticals Incorporated Azolylaminoazines as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
ES2273043T3 (es) * 2002-08-02 2007-05-01 Vertex Pharmaceuticals Incorporated Composiciones de pirazol utiles como inhibidores de gsk-3.
WO2004072029A2 (en) * 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
US7592340B2 (en) * 2003-12-04 2009-09-22 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
ITMI20050222A1 (it) * 2005-02-15 2006-08-16 Milano Politecnico Lipidi cationici per la trasfezione di acidi nucleici
CA2619517A1 (en) * 2005-08-18 2007-02-22 Michael Mortimore Pyrazine kinase inhibitors
WO2007056163A2 (en) * 2005-11-03 2007-05-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
MX2009004807A (es) * 2006-11-02 2009-06-15 Vertex Pharma Aminopiridinas y aminopirimidinas utiles como inhibidores de proteina cinasa.
JP2010513567A (ja) * 2006-12-19 2010-04-30 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼの阻害剤として有用なアミノピリミジン
ATE526328T1 (de) * 2007-03-09 2011-10-15 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyrimidine
WO2008112642A1 (en) * 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
WO2008112646A1 (en) * 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
CA2683785A1 (en) 2007-04-13 2008-10-23 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
MX2009011812A (es) * 2007-05-02 2010-01-14 Vertex Pharma Aminopirimidinas utiles como inhibidores de cinasa.
MX2009011811A (es) * 2007-05-02 2010-01-14 Vertex Pharma Aminopirimidinas utiles como inhibidores de cinasa.
CA2685876A1 (en) 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
CN101687852A (zh) * 2007-05-24 2010-03-31 沃泰克斯药物股份有限公司 可用作激酶抑制剂的噻唑类和吡唑类化合物
AR067762A1 (es) * 2007-07-31 2009-10-21 Vertex Pharma Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma
KR20110050549A (ko) * 2008-09-03 2011-05-13 버텍스 파마슈티칼스 인코포레이티드 공-결정 및 이를 포함하는 제약 제제
ES2740424T3 (es) 2009-03-13 2020-02-05 Agios Pharmaceuticals Inc Métodos y composiciones para trastornos relacionados con la proliferación celular
SG10201403696UA (en) 2009-06-29 2014-10-30 Agios Pharmaceuticals Inc Therapeutic compounds and compositions
EP3064595B1 (en) 2009-10-21 2019-02-27 Agios Pharmaceuticals, Inc. Methods for cell-proliferation-related disorders
JP6272754B2 (ja) 2011-05-03 2018-01-31 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼ活性化剤の使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
WO2013018071A2 (en) * 2011-08-04 2013-02-07 Colourtex Industries Limited Fibre reactive azo reactive colorants containing two reactive groups of the vinylsulfone type, production and use thereof
KR101945073B1 (ko) * 2011-08-12 2019-02-01 우베 고산 가부시키가이샤 폴리이미드 전구체, 폴리이미드, 폴리이미드 필름, 및 이들의 제조에 사용되는 트리아진 화합물의 제조 방법
LT2800743T (lt) 2012-01-06 2018-06-25 Agios Pharmaceuticals, Inc. Terapiškai aktyvūs junginiai ir jų panaudojimo būdai
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
JP6082390B2 (ja) * 2012-05-14 2017-02-15 国立大学法人岩手大学 ポリイミド前駆体、ポリイミド、ポリイミドフィルム、ポリイミド金属積層体およびポリイミド溶液
NZ706999A (en) 2012-10-15 2018-12-21 Agios Pharmaceuticals Inc Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof
ES2807582T3 (es) 2013-07-11 2021-02-23 Agios Pharmaceuticals Inc Compuestos N,6-bis(aril o heteroaril)-1,3,5-triazina-2,4-diamina como inhibidores de mutantes IDH2 para el tratamiento del cáncer
US10376510B2 (en) 2013-07-11 2019-08-13 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
CN105473560B (zh) * 2013-07-11 2020-01-17 安吉奥斯医药品有限公司 治疗活性化合物及其使用方法
WO2015010297A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9968595B2 (en) 2014-03-14 2018-05-15 Agios Pharmaceuticals, Inc. Pharmaceutical compositions of therapeutically active compounds
RS64777B1 (sr) 2015-06-11 2023-11-30 Agios Pharmaceuticals Inc Postupci upotrebe aktivatora piruvat kinaze
DK3362066T3 (da) 2015-10-15 2021-11-22 Les Laboratoires Servier Sas Kombinationsterapi til behandling af maligniteter
UA123401C2 (uk) 2015-10-15 2021-03-31 Аджиос Фармасьютікалз, Інк. Комбінована терапія для лікування злоякісних пухлин
CN108640881A (zh) * 2018-04-26 2018-10-12 江汉大学 一种二胺单体及其合成方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
CN116790213B (zh) * 2023-07-04 2024-02-20 江苏特丽亮新材料科技有限公司 一种耐高温导电胶及其制备方法
CN118652248B (zh) * 2024-05-29 2025-02-14 南京理工大学 6-(4-氨基-1,2,5-噁二唑-3-基)-1,3,5-三嗪-2,4-二胺及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH441351A (de) * 1964-06-02 1967-08-15 Geigy Ag J R Verfahren zur Herstellung N2-substituierter 2,4,6-Triamino-1,3,5-triazine
DE1620178A1 (de) * 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
US3637685A (en) * 1967-05-15 1972-01-25 Monacelli Walter J Triamino-s-triazines

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774235B2 (en) 1998-03-27 2004-08-10 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives
KR100593396B1 (ko) * 1998-03-27 2006-06-28 얀센 파마슈티카 엔.브이. Ｈｉｖ 감염을 치료하기 위한 삼치환된 1,3,5-트리아진유도체
BG64903B1 (bg) * 1998-03-27 2006-08-31 Janssen Pharmaceutica N.V. Тризаместени 1, 3, 5-триазинови производни за лечение на hiv-инфекции
US6150360A (en) * 1998-03-27 2000-11-21 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-Triazine Derivatives
US6372729B1 (en) 1998-03-27 2002-04-16 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5,-triazine derivatives
AP1475A (en) * 1998-03-27 2005-10-03 Janssen Pharmaceutica Nv Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections.
WO1999050256A1 (en) * 1998-03-27 1999-10-07 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections
EP0945447A1 (en) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
US7015221B2 (en) 1998-11-10 2006-03-21 Janssen Pharmaceutica, N.V. 2,4-disubstituted triazine derivatives
US6638932B1 (en) 1998-11-10 2003-10-28 Janssen Pharmaceutica N.V. 2,4-disubstituted triazine derivatives
AP1636A (en) * 1998-11-10 2006-07-17 Janssen Pharmaceutica Nv 2.4-disubstituted triazine derivatives.
WO2000027828A3 (en) * 1998-11-10 2000-09-21 Janssen Pharmaceutica Nv 2,4-disubstituted triazine derivatives with anti hiv activity
US7241458B1 (en) 1999-09-24 2007-07-10 Janssen Pharmaceutica N.V. Antiviral compositions
US7887845B2 (en) 1999-09-24 2011-02-15 Janssen Pharmaceutica Nv Antiviral compositions
WO2006024175A1 (en) * 2004-09-03 2006-03-09 Prometic Biosciences Inc. 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE

Also Published As

Publication number Publication date
BE754242A (fr) 1971-02-01
GB1339749A (en) 1973-12-05
AU1826570A (en) 1972-02-03
US3755322A (en) 1973-08-28
AT299216B (de) 1972-06-12
NL7011392A (OSRAM) 1972-01-18
AT299965B (de) 1972-07-10
CA982577A (en) 1976-01-27

Similar Documents

Publication Publication Date Title
DK130321C (OSRAM)
DK130386C (OSRAM)
CS153582B2 (OSRAM)
FR2074501A5 (OSRAM)
DK130194C (OSRAM)
AU3444071A (OSRAM)
DK136495C (OSRAM)
DE2021332B2 (OSRAM)
FR2074690B1 (OSRAM)
DE2040242B2 (OSRAM)
CS157707B2 (OSRAM)
FR2081634B1 (OSRAM)
DK136064C (OSRAM)
DK131568C (OSRAM)
DE2038918A1 (OSRAM)
CS173589B2 (OSRAM)
CS149431B2 (OSRAM)
DE2162826B2 (OSRAM)
DE2064455C3 (OSRAM)
FR2037918A5 (OSRAM)
FR2087519A5 (OSRAM)
DK130207C (OSRAM)
DE2064245C3 (OSRAM)
DE2040383C3 (OSRAM)
FR2080162A5 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse